Company Search:
Advanced Search
Sponsored Links
Opiant Pharmaceuticals Inc Company Snapshot
Opiant Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Opiant Pharmaceuticals Inc with three other companies in this sector in Canada: Ceapro Inc (2016 sales of 13.67 million Canadian Dollars [US$10.45 million] ), Microbix Biosystems Inc (9.52 million Canadian Dollars [US$7.27 million] ), and Neptune Technologies & Bioressources Inc (22.63 million Canadian Dollars [US$17.29 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Opiant Pharmaceuticals Inc
  Stock Performance Chart for Opiant Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 27.03
(Figures in Canadian Dollars)
1 Week 4.0%   13 Weeks -15.2%  
4 Weeks -6.8%   52 Weeks 153.1%  
Opiant Pharmaceuticals Inc Key Data:
  Ticker: OPNT Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 13,092,044
(Year Ending Jan 2017).
Employees: 3
  Currency: Canadian Dollars Market Cap: 55,896,770
  Fiscal Yr Ends: July Shares Outstanding: 2,067,888
  Share Type: Common Closely Held Shares: 484,285
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.